Lazard Transactions
DISCLAIMER: Transaction value is approximate and is based on information disclosed by the parties to the transaction or other public sources. In addition, in the case of transactions consummated in currencies other than U.S. dollars, Lazard has converted the value using the exchange rate published on the date of announcement. Lazard makes no representation or warranty with respect to the accuracy or completeness of the value provided
Download results
Showing 1 to 10 of 1313 Results
April 23, 2026
Isabel Marant Successfully Completed a Consent Solicitation Relating to its €265,000,000 8.000% Senior Secured Notes, Extending Maturity to September 1, 2030
$310.8 Million
April 20, 2026
Lazard acted as Financial Advisor to Loxam on its new and upsized €500m RCF to bolster liquidity and growth
$588.2 Million
March 20, 2026
Falfurrias Launches Crosslakes Next Growth Phase Through Single-Asset Continuation Fund Led by Leonard Green & Partners
Undisclosed
March 17, 2026
Lazard advises Fremman Capital on a continuation fund for Kids Planet
Undisclosed
March 16, 2026
Paratek Pharmaceuticals Completes Combination with Radius Health, Expanding Its MultiProduct Specialty Commercial Platform
$1.3 Billion
February 06, 2026
$9.4bn rights issue proceeds with 99.3% initial take-up and additional over-subscriptions
$9.4 Billion
February 06, 2026
Ørsted announces plan for a rights issue with support from the Danish State as majority shareholder and gross proceeds of DKK 60 billion
$9.3 Billion
January 26, 2026
Oviva Secures €200 Million to Expand AI-Enabled Healthcare Across Europe
$234 Million
January 21, 2026
GPS Group in Major €300 Million Infrastructure Refinancing
$348.9 Million
January 21, 2026